PMA supplement
P150033 S162: CareLink SmartSync™ Micra VR App, CareLink SmartSync™ Micra AV App
FDA PMA supplement · Real-Time Process · Medtronic, Inc.
Key facts
| Original PMA | P150033 |
|---|---|
| Supplement number | S162 |
| Supplement type | Real-Time Process |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | CareLink SmartSync™ Micra VR App, CareLink SmartSync™ Micra AV App |
| Generic name | Pacemaker/icd/crt non-implanted components |
| Applicant | Medtronic, Inc. |
| Product code | OSR |
| Received date | Nov 14, 2022 |
| Decision date | Jan 18, 2023 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: